Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

QUIZARTINIB vs RACECADOTRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

QUIZARTINIB vs RACECADOTRIL: Safety Overview

Metric QUIZARTINIB RACECADOTRIL
Total FAERS Reports 357 729
Deaths Reported 61 162
Death Rate 17.1% 22.2%
Hospitalizations 121 475
Average Patient Age 54.0 yrs 60.1 yrs
% Female Patients 57.9% 48.1%
FDA Approval Date Jul 20, 2023 N/A
Manufacturer Daiichi Sankyo Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A